Back to Search
Start Over
Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: Significance of intensive neoadjuvant chemotherapy and radiation break
- Source :
- Radiotherapy and Oncology. 96:94-99
- Publication Year :
- 2010
- Publisher :
- Elsevier BV, 2010.
-
Abstract
- To exam factors associated with overall survival (OS) in patients with nasopharyngeal carcinoma (NPC).This study is a retrospective study of a total of 1706 consecutive NPC patients from a single institution between January 1995 and December 1998. One thousand eighty-one patients were treated with radiotherapy (RT) alone and 625 with an intensive course of neoadjuvant chemotherapy followed by RT. Patient, tumor and treatment factors were analyzed for their significance on 5-year overall survival (OS).Younger age, female gender, absence of anemia pre-RT, early tumor stage, interruption of RT, and neoadjuvant chemotherapy were significantly associated with survival under multivariate analysis (all P0.05). The 5-year OS rates were 100%, 75.9% (95%CI 71.6-80.2%), 66.5% (95%CI 62.8-70.2%), and 49.3% (95%CI 45.0-53.6%) for stage I, II, III, and IV (P0.05); 68.9% (95%CI 66.2-71.5%) and 63.7% (95%CI 61.5-65.8%), for patients treated with or without neoadjuvant chemotherapy (P=0.0051), and 51.7% (95%CI 45.0-58.4%) and 69.5% (95%CI 67.2-71.7%) for patients with or without treatment break (P0.0001), respectively.Intensive neoadjuvant chemotherapy and absence of radiation break seem to be favorable factors associated with long-term survival in patients with NPC.
- Subjects :
- Adult
Male
Oncology
China
medicine.medical_specialty
Time Factors
Multivariate analysis
Anemia
medicine.medical_treatment
Kaplan-Meier Estimate
Disease-Free Survival
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
medicine
Humans
Neoplasm Invasiveness
Radiology, Nuclear Medicine and imaging
Survival analysis
Aged
Neoplasm Staging
Proportional Hazards Models
Retrospective Studies
Aged, 80 and over
Chemotherapy
Dose-Response Relationship, Drug
Proportional hazards model
business.industry
Dose-Response Relationship, Radiation
Nasopharyngeal Neoplasms
Radiotherapy Dosage
Retrospective cohort study
Hematology
Middle Aged
Prognosis
medicine.disease
Combined Modality Therapy
Survival Analysis
Neoadjuvant Therapy
Radiation therapy
Treatment Outcome
Nasopharyngeal carcinoma
Chemotherapy, Adjuvant
Multivariate Analysis
Female
Radiotherapy, Adjuvant
business
Subjects
Details
- ISSN :
- 01678140
- Volume :
- 96
- Database :
- OpenAIRE
- Journal :
- Radiotherapy and Oncology
- Accession number :
- edsair.doi.dedup.....2c00c029f8dc4fbc5b6929de12e6e48f
- Full Text :
- https://doi.org/10.1016/j.radonc.2010.04.006